GoalNav® Clinic Module - Pilot Trial

September 19, 2025 updated by: Ardea Outcomes
This is a pilot study to test the feasibility of GoalNav® Clinic, an Electronic Data Capture platform which is specifically designed to collect data on patient goals, live in a clinical setting.

Study Overview

Detailed Description

Goal Attainment Scaling (GAS) is an individualized outcome measure that quantifies the effects of an intervention based on personalized goals.

Ardea Outcomes has developed an electronic data capture system called GoalNav® Clinic that is designed to capture GAS data (individual goals) in addition to other outcome measures that is useful to the doctor such as assessment information, patient demographics, cognitive status, etc..

With the help of a study doctor and/or a member of the research team trained in the process of conducting GAS interviews, patients and/or care partners set goals that are meaningful and relevant to them or their loved one's condition. Goals are then followed up in three months, and ratings are provided by the GAS interviewer and patient and/or care partner.

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nova Scotia
      • Cape Breton, Nova Scotia, Canada, B1M 0A1
        • Geriatric Medicine & Memory Disability Clinic, Cape Breton Regional Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • a new or returning patient who has been referred and has a pre-scheduled appointment to the study doctor's clinic for a geriatric assessment
  • of any age, with or without a disease diagnosis/memory complaint
  • the patient is accompanied by a family member or friend who is willing to participate
  • the patient and/or their care partner must be able to respond to questions in English
  • the patient and their care partner give informed consent

Exclusion Criteria:

  • the patient does not have a family member or friend who is willing to participate
  • neither the patient nor their care partner can respond to questions in English
  • either or both the patient and care partner decline to provide informed consent
  • the study doctor deems that the patient and/or care partner is not suitable for the study
  • either the patient or their care partner indicates on the informed consent form that they do not wish to be contacted by email or by telephone

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm A - Inventory
Goal Attainment Scaling (GAS) with goal inventory
Goal Attainment Scaling (GAS) with a goal inventory (list of common goals) as a behavioral interventional tool
Active Comparator: Arm B - No Inventory
Goal Attainment Scaling (GAS) without goal inventory
Goal Attainment Scaling (GAS) without a goal inventory (list of common goals) as a behavioral interventional tool

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Goal Setting Survey
Time Frame: 4 months
The goal setting survey includes multiple choice, Likert type and open-ended questions with respect to the feasibility and acceptability of Goal Attainment Scaling. The questions focus on the impressions and experiences of patients and care partners (in Arm A and Arm B), and the study doctors when conducting interviews using GoalNav® EDC with and without goal inventory. The percentage of participants agreeing with statements with respect to ease of use, time commitment, etc. will be the unit of measurement. The answers to the open-ended questions will also be qualitatively analyzed.
4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
GAS Interviewer Individual Qualitative Interview
Time Frame: 4 months

The one-hour qualitative interview with GAS interviewers will include questions such as

  • did GAS interviewers use the goal inventory for participants in Arm B (no goal inventory)?
  • was there a difference between Arm A and Arm B in the goal setting process?
  • was there a difference between Arm A and Arm B in goal quality?
  • did patients and care partners in Arm B find it difficult to identify challenges or goal areas without sufficient prompts?
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Arlene Kelly-Wiggins, MD, Nova Scotial Health

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 26, 2023

Primary Completion (Actual)

November 30, 2024

Study Completion (Actual)

November 30, 2024

Study Registration Dates

First Submitted

August 9, 2023

First Submitted That Met QC Criteria

August 24, 2023

First Posted (Actual)

August 31, 2023

Study Record Updates

Last Update Posted (Estimated)

September 24, 2025

Last Update Submitted That Met QC Criteria

September 19, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • GoalNavRCC2023

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Geriatric Assessment

Clinical Trials on Goal Attainment Scaling (GAS) with a goal inventory

Subscribe